[1]武相锋,刘 韬,张 倩.促血管生成因子对糖尿病足作用机制的研究进展[J].医学信息,2018,(20):18-22.[doi:10.3969/j.issn.1006-1959.2018.20.007]
 WU Xiang-feng,LIU Tao,ZHANG Qian.Advances in Research on the Mechanism of Pro-angiogenic Factors on Diabetic Foot[J].Medical Information,2018,(20):18-22.[doi:10.3969/j.issn.1006-1959.2018.20.007]
点击复制

促血管生成因子对糖尿病足作用机制的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年20期
页码:
18-22
栏目:
综述
出版日期:
2018-10-15

文章信息/Info

Title:
Advances in Research on the Mechanism of Pro-angiogenic Factors on Diabetic Foot
文章编号:
1006-1959(2018)20-0018-05
作者:
武相锋1刘 韬2张 倩2
1.牡丹江医学院,黑龙江 牡丹江 157011;2.深圳市罗湖区人民医院,广东 深圳 518000
Author(s):
WU Xiang-feng1LIU Tao2ZHANG Qian2
1.Mudanjiang Medical College,Mudanjiang 157011,Heilongjiang,China;2.Shenzhen Luohu District People's Hospital,Shenzhen 518000,Guangdong,China
关键词:
糖尿病足促血管生成因子再生医学缺血/再灌注损伤
Keywords:
Diabetic footPro-angiogenic factorRegenerative medicineIschemia/reperfusion injury
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2018.20.007
文献标志码:
A
摘要:
糖尿病足是继发于糖尿病终末期的下肢溃疡缺血性疾病。促血管生成因子在糖尿病下肢缺血性疾病中的作用机制十分复杂,不同促血管生成因子发挥的作用不尽相同。在缺血损伤区域的修复过程中,促血管生成因子的表达上升,参与组织缺血损伤区血管结构的重建,改善局部血液循环,使组织缺血损伤得到修复。病理情况下,促血管生成因子参与炎症级联反应,与缺血/再灌注损伤关系密切,还可能诱导硬化斑块破裂、增加能量的代谢消耗,产生不利影响。近年来,随着再生医学研究的深入,促血管生成因子开始应用于糖尿病足的治疗中,逐渐成为糖尿病足新的治疗靶点。
Abstract:
Diabetic foot is an ischemic disease of the lower extremity ulcer secondary to the end stage of diabetes.The mechanism of action of angiogenic factors in diabetic lower limb ischemic diseases is very complex,and different pro-angiogenic factors play different roles.During the repair of ischemic injury,the expression of pro-angiogenic factors increases,participates in the reconstruction of vascular structures in the ischemic injury area,improves local blood circulation,and repairs tissue ischemic injury.In pathological conditions,pro-angiogenic factors are involved in the inflammatory cascade,which is closely related to ischemia/reperfusion injury.It may also induce plaque rupture,increase energy metabolism,and have adverse effects.In recent years,with the deepening of regenerative medicine research,pro-angiogenic factors have begun to be used in the treatment of diabetic foot,and have gradually become a new therapeutic target for diabetic foot.

参考文献/References:

[1]Jhamb S,Vangaveti VN,Malabu UH.Genetic and molecular basis of diabetic foot ulcers: Clinical review [J].J Tissue Viability,2016,25(4):229-236. [2]Bisserier M,Berthouze-Duquesnes M,Breckler M,et al.Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+calmodulin-dependent protein kinase Ⅱ signaling[J].Circulation,2015,131(4):390. [3]Okabe K,Yamada Y,Ito K,et al.Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stem cells,platelet-rich plasma,and hyaluronic acid scaffolds[J].Cytotherapy,2009,11(3):307-316. [4]Mozaffarian D,Benjamin EJ,Go AS,et al.Heart disease and stroke statistics--2015 update:a report from the American Heart Association[J].Circulation,2015,131(4):e29. [5]Sandri M,Viehmann M,Adams V,et al.Chronic heart failure and aging-effects of exercise training on endothelial function and mechanisms of endothelial regeneration:Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA)study [J].Eur J Prev Cardiol,2016,23(4):349. [6]Xiao J,Gao H,Jin Y,et al.The abnormal expressions of tristetraprolin and the VEGF family in uraemic rats with peritoneal dialysis[J].Mol Cell Biol,2014,392(1-2):229. [7]常青,薛茜,张耀元,等.氯吡格雷联合阿司匹林序贯疗法治疗老年短暂性脑缺血发作的效果及对血清血管内皮生长因子、基质金属蛋白酶-9、血管紧张素-Ⅱ水平的影响[J].中国老年学杂志,2018,38(03):524-526. [8]Catar R,Witowski J,Wagner P,et al.The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation [J].Kidney Int,2013,84(6):1119-1128. [9]Sara M Weis,David A Cheresh.Tumor angiogenesis: molecular pathways and therapeutic targets[J].Nat Med,2011,17(11):1359-1370. [10]Carmeliet P,Jain RK.Molecular mechanisms and clinical applications of angiogenesis[J].Nature,2011,473(7347):298-307. [11]戴宇翔,王审,李晨光,等.梗死心肌侧枝血管形成与缺氧诱导因子-1α及血管内皮生长因子A表达水平的关系及临床意义[J].中国临床医学,2015(3):305-309. [12]Wang H,Zhang K,Zhao L,et al.Anti-inflammatory effects of vinpocetine on the functional expression of nuclear factor-kappa B and tumor necrosis factor-alpha in a rat model of cerebral ischemia-reperfusion injury[J].Neurosci Lett,2014,566(18):247-251. [13]陈成,钱军岭,陈涛,等.血管内皮生长因子促进慢性心肌梗死血管生成[J].医学研究杂志,2016,45(11):32-34. [14]项洁,吴鑫,陆晓,等.兔骨骼肌生理性缺血对缺氧诱导因子-1α的表达和血管内皮生长因子释放的影响[J].中国康复医学杂志,2016,31(10):1055-1059. [15]Adams JC,Lawler J.The thrombospondins[J].Int J Biochem Cell,2004,36(6):961-968. [16]Lawler J.The functions of thrombospondin-1 and-2[J].Curr Opin Cell Biol,2000,12(5): 634-640. [17]Chistiakov DA,Melnichenko AA,Myasoedova VA,et al.Thrombospondins:A role in cardiovascular disease[J].Int J Mol Sci,2017,18(7):1540. [18]S Muppala,R Xiao,I Krukovets,et al.Thrombospondin-4 mediates TGF-β-induced angiogenesis [J].Oncogene,2017,36(36):5189-5198. [19]Su F,Zhao J,Qin S,et al.Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma[J].Oncotarget,2017,8(14):23277-23288. [20]Subrammaniyan R,Amalorpavanathan J,Shankar R,et al.Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes:our experience[J].Cytotherapy,2011(13):993-999. [21]Layman H,Rahnemai-Azar AA,Pham SM,et al.Synergistic angiogenic effect of code-livering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia[J].Tissue Eng Part A,2011(17):243-254. [22]Osawa H,Orii K,Terunuma H,et al.Combining autologous peripheral blood mononuclear cells with fibroblast growth factor therapy along with stringent infection control leading to successful limb salvage in diabetic patient with chronic renal failure and severe toe gangrene[J].Int J Stem Cells,2014,7(2):158-161. [23]Botusan IR,Sunkari VG,Savu O,et al.Stabilization of HIF-1α is critical to improve wound healing in diabetic mice[J].Proc Natl Acad Sci U S A,2008,105(49):19426-19431. [24]Amin AH,Elmageed ZYA,Nair D,et al.Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice[J].Lab Invest,2010,90(7):985-996. [25]Zhang EY,Gao B,Shi HL,et al.20(S)-Protopanaxadiol enhances angiogenesis via HIF-1|[alpha]|-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice[J].Exp Mol Med,2017,49(10):e387. [26]Gopinathan G,Milagre C,Pearce OMT,et al.Interleukin-6 stimulates defective angiogenesis[J].Cancer Res,2015,75(15):3098-3107. [27]Huang SP,Wu MS,Shun CT,et al.Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma[J].J Biomed Sci,2004(11):517-527. [28]Wei LH,Kuo ML,Chen CA,et al.Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway[J].Oncogene,2003(22)1517-1527. [29]Nagasaki T,Hara M,Nakanishi H,et al.Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis:anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction[J].Br J Cancer,2014(110):469-478. [30]Mar AC,Chu CH,Lee HJ,et al.Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce angiogenesis [J].J Biol Chem,2015,290(36):22212-22224. [31]Jeon HJ,Choi HJ,Park BH,et al.Association of monocyte chemoattractant protein-1(MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes [J].Yonsei Med J,2013,54(3):621-625. [32]Carr CL.Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus[J].Arterioscl Throm Vas,2011,31(11):2526. [33]Waltenberger J,Lange J,Kranz A.Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus a potential predictor for the individual capacity to develop collaterals [J].Circulation,2000,102(2):185-190. [34]Lv Y,Ge L,Zhao Y.Effect and mechanism of SHED on ulcer wound healing in Sprague-Dawley rat models with diabetic ulcer[J].Am J Transl Res,2017,9(2):489. [35]Muppala S,Frolova E,Xiao R,et al.Proangiogenic properties of thrombospondin-4[J].Arterioscl Throm Vas,2015,35(9):1975. [36]Fleiner M,Kummer M,Mirlacher M,et al.Arterial neovascularization and inflammation in vulnerable patients:early and late signs of symptomatic atherosclerosis[J].Circulation,2004,110(18): 2843-2850.

相似文献/References:

[1]文虹杰,杨华刚,韩 涛,等.胫骨横向骨搬移术治疗糖尿病足的临床效果观察[J].医学信息,2018,(07):184.[doi:10.3969/j.issn.1006-1959.2018.07.066]
 WEN Hong-jie,YANG Hua-gang,HAN Tao,et al.Clinical Observation on the Treatment of Diabetic Foot with Transverse Tibial Bone Movement[J].Medical Information,2018,(20):184.[doi:10.3969/j.issn.1006-1959.2018.07.066]
[2]谢勇琼,高金姣.糖尿病足伤口处理中的护理风险及其相关性研究[J].医学信息,2018,(13):115.[doi:10.3969/j.issn.1006-1959.2018.13.034]
 XIE Yong-qiong,GAO Jin-jiao.Nursing Risk and its Correlation in Wound Management of Diabetic Foot[J].Medical Information,2018,(20):115.[doi:10.3969/j.issn.1006-1959.2018.13.034]
[3]郭燕青,陈四萍,何丽娟,等.基于VAS评分改进的护理模式对糖尿病足患者的影响[J].医学信息,2018,(16):172.[doi:10.3969/j.issn.1006-1959.2018.16.055]
 GUO Yan-qing,CHEN Si-ping,HE Li-juan,et al.Effect of Improved Nursing Model Based on VAS Score on Patients with Diabetic Foot[J].Medical Information,2018,(20):172.[doi:10.3969/j.issn.1006-1959.2018.16.055]

更新日期/Last Update: 2018-11-09